Actively Recruiting
Evaluation of Hemodynamic Changes During Craniosynostosis Surgery Comparing Traditional and Pressure Recording Analytic Method Monitoring
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-10-03
30
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying hemodynamic changes during corrective craniosynostosis surgery in infants aged 3 to 8 months. Craniosynostosis is a condition where the skull bones fuse too early, potentially leading to increased brain pressure and developmental delays. The study aims to better understand cardiovascular stability during surgery by comparing traditional monitoring methods with a new technology called the Pressure Recording Analytic Method PRAM. During surgery under general anesthesia, infants are monitored using standard devices alongside the MostCare system with PRAM technology. This advanced method continuously analyzes arterial blood pressure to estimate heart function and blood flow parameters. Data are collected every few minutes throughout the surgery to capture dynamic cardiovascular changes. Parents can expect their child to undergo usual anesthesiological care including fasting and pain management. Monitoring includes pulse oximetry, cerebral oxygen levels, and optional brain function tracking. The study closely observes blood volume, vascular resistance, and cardiac performance during surgery. Safety is maintained by experienced anesthesiologists and continuous data collection. Participation covers the surgery duration, with no additional long-term follow-up mentioned.
CONDITIONS
Brief Title
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants with craniosynostosis undergoing corrective surgery
- Ages between 3 and 8 months
- Physical status classification of the American Society of Anesthesiologists (ASA) �3c= 2
- Consent obtained from the patients' parents/legal guardians
You will not qualify if you...
- Congenital or acquired cardiac disease
- Preoperative cardiac dysfunction
- Metabolic diseases
- Gestational age at birth <30 weeks
- Body weight less than 3 kg
- Dislocation or malfunction of the arterial catheter
- Malfunctioning of monitoring devices
Research Team
M
Maria Cristina Mondardini, MD
F
Fabio Caramelli, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here